Precision health company developing medical imaging for metabolic disease and cancer
| Date | Round | Amount |
|---|---|---|
| Mar 2023 | Series C Perspectum closed a $55M Series C led by Oppenheimer, bringing total funding to $140M. | $55M |
| Jan 2023 | Series C Perspectum, a UK precision-health imaging company, raised a USD36M Series C led by Oppenheimer Holdings. | $36M |